BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1228 related articles for article (PubMed ID: 16213679)

  • 61. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women.
    Cayan F; Dilek U; Pata O; Dilek S
    J Sex Med; 2008 Jan; 5(1):132-8. PubMed ID: 17961145
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women.
    Levine KB; Williams RE; Hartmann KE
    Menopause; 2008; 15(4 Pt 1):661-6. PubMed ID: 18698279
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Correlated genetic and non-shared environmental influences account for the co-morbidity between female sexual dysfunctions.
    Witting K; Santtila P; Rijsdijk F; Varjonen M; Jern P; Johansson A; von der Pahlen B; Alanko K; Sandnabba NK
    Psychol Med; 2009 Jan; 39(1):115-27. PubMed ID: 18366817
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sexual arousal and lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary findings from the hypoactive sexual desire disorder registry for women.
    Maserejian NN; Shifren J; Parish SJ; Segraves RT; Huang L; Rosen RC
    J Sex Marital Ther; 2012; 38(1):41-62. PubMed ID: 22268981
    [TBL] [Abstract][Full Text] [Related]  

  • 65. LEI (Lack of tEstosterone Impact) survey in a clinical sample with surgical menopause.
    Nappi RE; Lello S; Melis GB; Albani F; Polatti F; Genazzani AR
    Climacteric; 2009 Dec; 12(6):533-40. PubMed ID: 19905905
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Web-based survey on the effect of menopause on women's libido in a computer-literate population.
    Cumming GP; Currie HD; Moncur R; Lee AJ
    Menopause Int; 2009 Mar; 15(1):8-12. PubMed ID: 19237616
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sexual satisfaction of women partners of circumcised men in a randomized trial of male circumcision in Rakai, Uganda.
    Kigozi G; Lukabwe I; Kagaayi J; Wawer MJ; Nantume B; Kigozi G; Nalugoda F; Kiwanuka N; Wabwire-Mangen F; Serwadda D; Ridzon R; Buwembo D; Nabukenya D; Watya S; Lutalo T; Nkale J; Gray RH
    BJU Int; 2009 Dec; 104(11):1698-701. PubMed ID: 19522862
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predicting sexual problems in women: the relevance of sexual excitation and sexual inhibition.
    Sanders SA; Graham CA; Milhausen RR
    Arch Sex Behav; 2008 Apr; 37(2):241-51. PubMed ID: 17902042
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Female sexual dysfunction as adverse effect of pharmacological treatment].
    Giraldi AG; Victor J
    Ugeskr Laeger; 2002 Oct; 164(41):4757-60. PubMed ID: 12407875
    [TBL] [Abstract][Full Text] [Related]  

  • 70. How do men and women define sexual desire and sexual arousal?
    Mitchell KR; Wellings KA; Graham C
    J Sex Marital Ther; 2014; 40(1):17-32. PubMed ID: 23819590
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quality of life impairment during the female menopausal transition is related to personal and partner factors.
    Chedraui P; San Miguel G; Avila C
    Gynecol Endocrinol; 2009 Feb; 25(2):130-5. PubMed ID: 19253110
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Demographic and psychological factors related to sexual desire among heterosexual women in a relationship.
    McCabe MP; Goldhammer DL
    J Sex Res; 2012; 49(1):78-87. PubMed ID: 21534027
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The impact of hormones on menopausal sexuality: a literature review.
    Bachmann GA; Leiblum SR
    Menopause; 2004; 11(1):120-30. PubMed ID: 14716193
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The enhancement of female sexual function with ArginMax, a nutritional supplement, among women differing in menopausal status.
    Ito TY; Polan ML; Whipple B; Trant AS
    J Sex Marital Ther; 2006; 32(5):369-78. PubMed ID: 16959660
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
    Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gender similarities and differences in sexual arousal, desire, and orgasmic pleasure in the laboratory.
    Paterson LQ; Jin ES; Amsel R; Binik YM
    J Sex Res; 2014; 51(7):801-13. PubMed ID: 24588445
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Assessment of sexual function and related factors in mid-aged sexually active Spanish women with the six-item Female Sex Function Index.
    Pérez-López FR; Fernández-Alonso AM; Trabalón-Pastor M; Vara C; Chedraui P;
    Menopause; 2012 Nov; 19(11):1224-30. PubMed ID: 22781787
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sexual function in menopausal women in Kelantan, Malaysia.
    Dhillon HK; Singh HJ; Ghaffar NA
    Maturitas; 2005; 52(3-4):256-63. PubMed ID: 15894440
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sexual functioning and patient expectations of sexual functioning after hysterectomy.
    Dragisic KG; Milad MP
    Am J Obstet Gynecol; 2004 May; 190(5):1416-8. PubMed ID: 15167854
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Factors associated with determinants of sexual functioning in midlife women.
    Tomic D; Gallicchio L; Whiteman MK; Lewis LM; Langenberg P; Flaws JA
    Maturitas; 2006 Jan; 53(2):144-57. PubMed ID: 16368468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.